Faruqi and Faruqui, LLP Logo
Share this page

Natus Medical Incorporated (BABY)

NASDAQ:BABY

Summary

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Natus Medical Incorporated To Contact The Firm Before Lead Plaintiff Deadline

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Natus Medical Incorporated (“Natus” or the “Company”) (NASDAQ:BABY) of the March 31, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.

The lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of all those who purchased Natus stock or options between October 16, 2015 and April 3, 2016 (the “Class Period”).  The case, Badger v. Natus Medical Incorporated et al., No. 17-cv-00458 was filed on January 30, 2017.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose the risk of unfulfilled payments from its contract with Venezuela’s Ministry of Health leading to a material decline in the Company’s revenues and profitability.

First, on October 16, 2015, Natus announced that its Argentinian subsidiary had entered into a three-year supply contract with the Ministry of Health of Venezuela pursuant to which the Company would receive $232.5 million, including $69 million in prepayments “expected” during the first quarter of 2016.

Then, on April 4, 2016, the Company announced lower-than-expected preliminary 2016 first quarter revenue of about $87.5 million, lower than its previous guidance of $91.5 million to $92.5 million, and below analysts’ expectations.  The Company cited the previously unexpected cancellation of payments in key Venezuelan government supply contracts as a reason for the disappointing results.

Take Action

If you invested in Natus stock or options between October 16, 2015 and April 3, 2016 and would like to discuss your legal rights, please fill out the form below. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Natus’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Request Information

Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you.

  • Case:
    Natus Medical Incorporated (BABY)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 01/31/2017

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.